Drug profile · INN
macimorelin acetate
MACRILEN
macimorelin acetate (MACRILEN) is a ghrelin receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — macimorelin acetate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
macimorelin acetate (MACRILEN) is a ghrelin receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Ghrelin receptor agonist
Primary target: Growth hormone secretagogue receptor type 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is macimorelin acetate?
macimorelin acetate (MACRILEN) is a ghrelin receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for macimorelin acetate?
MACRILEN is a marketed brand name for macimorelin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of macimorelin acetate?
macimorelin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.